Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo
Chinese Patent Office
Queensland Health

Generated: March 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075326

« Back to Dashboard

NDA 075326 describes TICLOPIDINE HYDROCHLORIDE, which is a drug marketed by Actavis Elizabeth, Apotex, Mylan, Sun Pharm Inds Inc, Teva, Watson Labs, and Yaopharma Co Ltd, and is included in nine NDAs. It is available from three suppliers. Additional details are available on the TICLOPIDINE HYDROCHLORIDE profile page.

The generic ingredient in TICLOPIDINE HYDROCHLORIDE is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ticlopidine hydrochloride profile page.
Summary for 075326
Applicant:Yaopharma Co Ltd
Ingredient:ticlopidine hydrochloride
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Pharmacology for NDA: 075326
Physiological EffectDecreased Platelet Aggregation
Suppliers and Packaging for NDA: 075326
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075326 ANDA Eon Labs, Inc. 0185-0115 E 0185-0115-30
TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075326 ANDA Eon Labs, Inc. 0185-0115 E 0185-0115-60

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Aug 20, 1999TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.